GNRH1 and adenomyosis: Although several studies indicated electronic data collection as a convenient way of implementing a continuous follow-up in regular time [34, 35], especially in electronic devices for home monitoring [36, 37], the follow-up timepoint is dynamic and unbalanced in patients with adenomyosis and menstrual disorders, especially after treatment, such as gonadotropin-releasing hormone (GnRH) cessation of menstruation to-be-decided [33].